TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 4 | 3 | -13 | 9 | 20 | -81 | -10 |
| P | %wins | 100 | 50 | 0 | 50 | 50 | 0 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/21/16 18:14 | 10/19/16 | BIOC | Biocept Inc | DE | Health | Health | Medical Laboratories | Singh Veena | CA | O | SVP,Sr M | P.d | 11 | 1.10 | 0 | 10 | 55 | 28 | D | -89 | -87 | -76 | -48 | -46 | -39 | -29 | 7 | 6 | 7 | -3 | 58 | 82 | |
6/2/15 14:04 | 5/29/15 | BIOC | Biocept Inc | DE | Health | Health | Medical Laboratories | Singh Veena | CA | O | SVP,Sr M | P.m | 15 | 3.08 | 2 | 5 | New | 5 | I | -26 | 0 | -10 | -2 | 8 | 13 | 9 | 2 | -1 | -22 | -40 | -43 | -81 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |